SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-116359
Filing Date
2024-11-12
Accepted
2024-11-12 07:23:31
Documents
4
Group Members
DR. BETH C. SEIDENBERGDR. SEAN E. HARPERWESTLAKE BIOPARTNERS GP I, LLCWESTLAKE BIOPARTNERS OPPORTUNITY FUND I, L.P.WESTLAKE BIOPARTNERS OPPORTUNITY GP I, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2427940d1_sc13g.htm SC 13G 109824
2 EXHIBIT 1 tm2427940d1_ex-1.htm EX-99.1 10475
3 EXHIBIT 2 tm2427940d1_ex-2.htm EX-99.2 9789
4 EXHIBIT 3 tm2427940d1_ex-3.htm EX-99.3 10097
  Complete submission text file 0001104659-24-116359.txt   142048
Mailing Address 3075 TOWNSGATE ROAD, SUITE 140 WESTLAKE VILLAGE CA 91361
Business Address 3075 TOWNSGATE ROAD, SUITE 140 WESTLAKE VILLAGE CA 91361 (650) 740-4070
Westlake BioPartners Fund I, L.P. (Filed by) CIK: 0001749591 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Subject) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94441 | Film No.: 241443274
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)